H.Res. 484 · 117th Congress

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Stage
In committee
Introduced
2021-06-17
Latest action
2022-11-01 · Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Cosponsors (23)

Mike Bost

Ted Budd

Tom Emmer

Bob Gibbs

Jody Hice